Biohaven Ltd.BHVNNYSE
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank74
3Y CAGR-21.2%
Year-over-Year Change
Year-over-year operating cash flow growth rate
3Y CAGR
-21.2%/yr
Quarterly compound
Percentile
P74
Within normal range
vs 3Y Ago
0.5x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 10.33% |
| Q3 2025 | 13.23% |
| Q2 2025 | -1.70% |
| Q1 2025 | 3.29% |
| Q4 2024 | -20.86% |
| Q3 2024 | 15.81% |
| Q2 2024 | -63.49% |
| Q1 2024 | 10.66% |
| Q4 2023 | -21.17% |
| Q3 2023 | -113.58% |
| Q2 2023 | 42.82% |
| Q1 2023 | -2.96% |
| Q4 2022 | 21.09% |
| Q3 2022 | -40.77% |
| Q2 2022 | -15.38% |
| Q1 2022 | -77.99% |
| Q4 2021 | 24.41% |
| Q3 2021 | -26.66% |
| Q2 2021 | 0.00% |
| Q1 2021 | 93.17% |
| Q4 2020 | 0.00% |
| Q3 2020 | 0.00% |
| Q2 2020 | 0.00% |
| Q1 2020 | 39.45% |
| Q4 2019 | 0.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 56.59% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q4 2017 | 0.00% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |